好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2014 Annual Meeting | 3FC.002 - Neurology Update I

Monday 04/28/14
09:00 AM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Full-Day Course
Joseph E. Safdieh, MD, FAAN
Participants should have knowledge of the most current recommendations for the diagnosis, management, and therapy of patients with the disorders discussed. The participants will be able to put recent developments in context so as to provide optimal patient care.

No CME available
Patient Care & Procedural Skills, Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Didactic
Event Timeline
09:00 AM - 09:45 AM Update on Dementia
Claudia Kawas, MD
09:45 AM - 10:30 AM Update in Neuro-Ophthalmology
Marc Dinkin, MD
10:30 AM - 10:45 AM Break
10:45 AM - 11:30 AM Update in Neuro-Oncology
Amy A. Pruitt, MD, FAAN
11:30 AM - 12:15 PM Update in Multiple Sclerosis
Stephen Krieger, MD, FAAN
12:15 PM - 01:15 PM Lunch
01:15 PM - 02:00 PM Update in Paraneoplastic and Autoimmune Neurology
Josep O. Dalmau, MD, PhD, FAAN
02:00 PM - 02:45 PM Update in Epilepsy
Steven C. Karceski, MD
02:45 PM - 03:00 PM Break
03:00 PM - 03:45 PM Update in Stroke
Cheryl Bushnell, MD, MHS
03:45 PM - 04:30 PM Update in Spine Disorders
J. D. Bartleson, MD, FAAN
04:30 PM - 05:00 PM Questions and Answers
Faculty Disclosures
J. D. Bartleson, MD, FAAN Dr. Bartleson has nothing to disclose.
Claudia Kawas, MD The institution of Dr. Kawas has received research support from NIH.
Amy A. Pruitt, MD, FAAN Dr. Pruitt has nothing to disclose.
Josep O. Dalmau, MD, PhD, FAAN Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care.
Steven C. Karceski, MD No disclosure on file
Cheryl Bushnell, MD, MHS Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Joseph E. Safdieh, MD, FAAN Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Marc Dinkin, MD Dr. Dinkin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for C U R T I S & C O . Attorneys and Counselors at Law. Dr. Dinkin has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Luks, Santiello. Dr. Dinkin has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Luks and Santaniello.
Stephen Krieger, MD, FAAN Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen.